Ticker Wall Street doesn’t want you to have
Former hedge fund manager Teeka Tiwari just released the name of his top pick for you to play this $867 trillion wrecking ball…

Details on 5 more tickers that could deliver 10X gains in the coming months as this massive financial trend picks up steam.
Click here to get the name of his top ticker

KRBP Insider Trading (Kiromic BioPharma)

Insider Ownership Percentage: 34.51%
Insider Buying (Last 12 Months): $10,360.00
Insider Selling (Last 12 Months): $0.00

Kiromic BioPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Kiromic BioPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kiromic BioPharma Share Price & Price History

Current Price: $1.24
Price Change: Price Decrease of -0.02 (-1.59%)
As of 01/21/2022 05:00 PM ET

This chart shows the closing price history over time for KRBP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Man who called 2020 Crash warns of huge event in 2022
A historic event in 2022 will cause a massive shift in the wealth divide. It could leave thousands of Americans under age 50 better off… while retirees will be left holding the scraps.
Details here…

Kiromic BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2021Maurizio Chiriva-InternatiCEOBuy2,800$3.70$10,360.001,378,072View SEC Filing Icon  
See Full Table
Insider Selling at Kiromic BioPharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Kiromic BioPharma and related companies.

SEC Filings (Institutional Ownership Changes) for Kiromic BioPharma (NASDAQ:KRBP)

15.81% of Kiromic BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KRBP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Kiromic BioPharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/27/2021Zeke Capital Advisors LLC56,899$0.18M0.0%+236.7%0.369%Search for SEC Filing on Google Icon
11/16/2021Intellectus Partners LLC98,850$0.30M0.1%+32.0%0.640%Search for SEC Filing on Google Icon
11/16/2021Warberg Asset Management LLC12,000$37K0.0%-81.0%0.078%Search for SEC Filing on Google Icon
11/16/2021LPL Financial LLC52,800$0.16M0.0%N/A0.342%Search for SEC Filing on Google Icon
11/12/20211492 Capital Management LLC434,408$1.33M0.7%+21.3%2.814%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC51,728$0.16M0.0%N/A0.335%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.30,645$94K0.0%+218.3%0.198%Search for SEC Filing on Google Icon
11/5/2021Resources Investment Advisors LLC.10,000$31K0.0%N/A0.065%Search for SEC Filing on Google Icon
11/5/2021K.J. Harrison & Partners Inc17,002$52K0.0%N/A0.110%Search for SEC Filing on Google Icon
10/14/2021WealthTrust Axiom LLC10,000$30K0.0%N/A0.065%Search for SEC Filing on Google Icon
8/17/2021Zeke Capital Advisors LLC16,899$81K0.0%-64.0%0.110%Search for SEC Filing on Google Icon
8/16/2021Warberg Asset Management LLC63,000$0.30M0.1%N/A0.409%Search for SEC Filing on Google Icon
8/16/2021Sabby Management LLC500,508$2.41M0.3%N/A3.253%Search for SEC Filing on Google Icon
8/16/2021Shay Capital LLC25,000$0.12M0.0%N/A0.162%Search for SEC Filing on Google Icon
8/13/2021Altium Capital Management LP333,475$1.60M0.4%N/A2.167%Search for SEC Filing on Google Icon
8/13/2021Murchinson Ltd.100,000$0.48M0.2%N/A0.650%Search for SEC Filing on Google Icon
8/13/2021Intellectus Partners LLC74,900$0.36M0.1%+96.3%0.487%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.119,304$0.57M0.0%+1,045.6%0.775%Search for SEC Filing on Google Icon
8/12/2021Kepos Capital LP767,000$3.69M0.3%N/A4.985%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC21,725$0.20M0.0%+86.7%0.295%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC21,725$0.20M0.0%+86.7%0.296%Search for SEC Filing on Google Icon
5/17/2021Intellectus Partners LLC38,150$0.36M0.1%+8.2%0.520%Search for SEC Filing on Google Icon
5/12/20211492 Capital Management LLC185,937$1.74M1.0%N/A2.536%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.5,117$48K0.0%+45.0%0.070%Search for SEC Filing on Google Icon
5/6/2021Redmond Asset Management LLC45,412$0.43M0.1%N/A0.619%Search for SEC Filing on Google Icon
4/21/2021Zeke Capital Advisors LLC46,999$0.44M0.0%-2.9%0.641%Search for SEC Filing on Google Icon
2/18/2021Intellectus Partners LLC35,250$0.30M0.1%N/A0.481%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.3,529$30K0.0%N/A0.048%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Kiromic BioPharma logo
Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1; and chimeric gamma delta PD1 T cell switch receptor therapy. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University, as well as research and development collaboration agreements with Molipharma, S.R.L. and Leon Office (H.K.). The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Read More on Kiromic BioPharma

Today's Range

Now: $1.24
Low: $1.13
High: $1.26

50 Day Range

MA: $1.95
Low: $1.13
High: $3.11

52 Week Range

Now: $1.24
Low: $1.05
High: $12.12

Volume

88,251 shs

Average Volume

98,675 shs

Market Capitalization

$19.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Kiromic BioPharma?

Kiromic BioPharma's top insider investors include:
  1. Internati Maurizio Chiriva (CEO)
  2. Jerry A Schneider (Director)
Ticker Wall Street doesn’t want you to have
Former hedge fund manager Teeka Tiwari just released the name of his top pick for you to play this $867 trillion wrecking ball…

Details on 5 more tickers that could deliver 10X gains in the coming months as this massive financial trend picks up steam.
Click here to get the name of his top ticker